Loading clinical trials...
Loading clinical trials...
This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas
Primary Objectives: Aim 1: To comprehensively assess barriers to and facilitators of receiving timely cancer treatment, via in-depth telephone interviews among a purposive sample of Texas patients with Stage I-IV breast, colorectal, lung, and prostate cancer and diverse backgrounds. Aim 2: To generate consensus on barriers and facilitators, as well as their relative importance, via focus groups, among carefully selected Texas patients with Stage I-IV breast, colorectal, lung and prostate cancer and diverse backgrounds,
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Start Date
January 31, 2026
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2028
Last Updated
March 2, 2026
120
ESTIMATED participants
Interviews
OTHER
Focus Groups
OTHER
Lead Sponsor
M.D. Anderson Cancer Center
NCT05691465
NCT05673200
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions